Article info

Download PDFPDF

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease
Free
  1. Correspondence to:
    Dr W J Sandborn
    Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA; sandborn.williammayo.edu
View Full Text

Citation

Sandborn WJ, Loftus EV
Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

Publication history

  • First published May 11, 2004.
Online issue publication 
May 11, 2004

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.